Back to companies
Edgewise Therapeutics, Inc.
EWTXUSNASDAQPharmaceuticals & HealthcareEdgewise Therapeutics, Inc.
Revenue
—
FY2025
Operating income
-$191.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API